[1]
“Assessment of Factors Affecting Therapeutic Response of the DPP-4 Inhibitor Sitagliptin in A Sample of Iraqi Type 2 Diabetic Patients”, AJPS, vol. 24, no. 3, pp. 311–319, Jul. 2024, doi: 10.32947/ajps.v24i3.1082.